The pharmaceutical field is experiencing a major shift in glucose treatment with the emergence of GLP-1 transdermal devices. These groundbreaking vehicles offer a potentially convenient choice to injections for individuals managing diabetes mellitus type 2. By bypassing the necessity for frequent needles, GLP-1 patches promise to enhance patient ad